International Journal of Inflammation

Inflammation in Retinal Disease


Publishing date
21 Jun 2013
Status
Published
Submission deadline
01 Feb 2013

1Allergan, Inc., Irvine, CA 92623-9534, USA

2Laboratory of Immunology, National Eye Institute, National Institute of Health, Bethesda, MD 20892-2510, USA

3UCL Institute of Ophthalmology, London EC1V 9EL, UK; Moorfields Eye Hospital, London EC1V 2PD, UK


Inflammation in Retinal Disease

Description

Ocular inflammation and its related complications are important causes of vision loss in a wide array of retinal diseases. While the inflammatory etiology of posterior uveitis has long been recognized, recent research efforts have revealed the critical role of inflammation underlying the pathophysiology of other diseases of the posterior segment, including retinal vein occlusion, diabetic retinopathy, Irvine-Gass syndrome, and age-related macular degeneration. Inflammation may contribute to breakdown of the blood-retinal barrier, vascular leakage, and macular edema, as well as the growth of new and abnormal blood vessels. Knowledge and understanding of the role of inflammation in these conditions has led to the development and use of anti-inflammatory therapies in the treatment of these retinal diseases.

We invite investigators to contribute original research articles as well as review articles that will add to the growing body of literature on the role of inflammation in retinal diseases as well as the evolving treatment paradigms for addressing the underlying inflammatory processes contributing to vision loss. We are interested in articles that explore the role of inflammation in posterior segment diseases and share new insights based on clinical trials. Potential topics include, but are not limited to:

  • Inflammation in the aging retina
  • Inflammation and the pathophysiology of retinal diseases (e.g., diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion)
  • Intraocular cytokines/growth factors and retinal diseases
  • Novel therapeutic targets of anti-inflammatory therapy in retinal diseases
  • Recent advances in ocular drug delivery for inflammatory retinal diseases
  • Role of surgery on inflammatory retinal diseases

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/iji/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/iji/ijrd/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 724648
  • - Editorial

Inflammation in Retinal Disease

Scott M. Whitcup | Robert B. Nussenblatt | ... | David A. Hollander
  • Special Issue
  • - Volume 2013
  • - Article ID 689276
  • - Review Article

The Evolving Treatment Options for Diabetic Macular Edema

Atul Jain | Neeta Varshney | Colin Smith
  • Special Issue
  • - Volume 2013
  • - Article ID 348092
  • - Review Article

The Role of the Immune Response in Age-Related Macular Degeneration

Scott M. Whitcup | Akrit Sodhi | ... | Andrew D. Dick
  • Special Issue
  • - Volume 2013
  • - Article ID 438412
  • - Review Article

Inflammation in Retinal Vein Occlusion

Avnish Deobhakta | Louis K. Chang
  • Special Issue
  • - Volume 2013
  • - Article ID 464127
  • - Research Article

Peripheral Fluorescein Angiographic Findings in Fellow Eyes of Patients with Branch Retinal Vein Occlusion

Irena Tsui | Asima Bajwa | ... | Steven D. Schwartz
  • Special Issue
  • - Volume 2013
  • - Article ID 503725
  • - Research Article

Infiltration of Proinflammatory M1 Macrophages into the Outer Retina Precedes Damage in a Mouse Model of Age-Related Macular Degeneration

Fernando Cruz-Guilloty | Ali M. Saeed | ... | Victor L. Perez
  • Special Issue
  • - Volume 2013
  • - Article ID 581751
  • - Review Article

Targeting Inflammation in Emerging Therapies for Genetic Retinal Disease

Ishaq A. Viringipurampeer | Abu E. Bashar | ... | Kevin Gregory-Evans
  • Special Issue
  • - Volume 2013
  • - Article ID 281981
  • - Review Article

Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease

Scott D. Schoenberger | Stephen J. Kim
International Journal of Inflammation
 Journal metrics
Acceptance rate13%
Submission to final decision64 days
Acceptance to publication36 days
CiteScore5.500
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.